Axsome Therapeutics Inc (NASDAQ:AXSM)
| 62.84 Delayed Data As of 3:59pm ET |  -2.18 / -3.35%Today’s Change | 35.44 Today|||52-Week Range 109.53 | -22.87% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 48.0M | 36.6M | 34.0M | 14.0M | |
| Short Term Investment Cash | 45.4M | -11.4M | -2.6M | -20.1M | ||
| Cash & Short Term Investments | 48.0M | 36.6M | 34.0M | 14.0M | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 996.6K | 1.4M | 1.3M | 1.2M | |
| Current Assets | 49.0M | 38.0M | 35.3M | 15.2M | ||
| Total Assets | Other Assets | 26.6K | 112.8K | 188.0K | 112.3K | |
| Total Assets | 49.1M | 38.2M | 35.6M | 15.4M | ||
| Liabilities | Accounts Payable | 0.00 | 0.00 | 3.4M | 3.7M | |
| Short Term Debt | 0.00 | 269.2K | 3.3M | 3.3M | ||
| Accrued Expenses | 408.8K | 2.3M | 2.0M | 2.8M | ||
| Other Current Liabilities | 2.3M | 6.4M | 4.8M | 2.8M | ||
| Other Liabilities | 2.6M | 7.2M | 12.2M | 10.8M | ||
| Total Liabilities | Long Term Debt | 0.00 | 9.5M | 6.7M | 3.6M | |
| Total Liabilities | 2.6M | 16.6M | 18.8M | 14.4M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 46.4M | 21.6M | 16.7M | 937.9K | ||
| Total Shareholder Equity | 46.4M | 21.6M | 16.7M | 937.9K | ||
| Share Information | Common Shares Outstanding | 19.1M | 19.2M | 25.5M | 30.1M | |
| Addtl. Info. | No data currently available for this section. | |||||
